TipRanks

Notifications

Tag: BDTX

Total 105 Posts

Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and I-MAB (IMAB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Black Diamond Therapeutics (BDTXResearch Report) and I-MAB (IMABResearch Report) with bullish sentiments.

Black Diamond Therapeutics (BDTX)

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics, with a price target of $12.00. The company’s shares closed last Friday at $4.79.

According to TipRanks.com, Burns ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -23.0% and a 24.0% success rate. Burns covers the Healthcare sector, focusing on stocks such as Springworks Therapeutics, Atara Biotherapeutics, and Allogene Therapeutics.

Currently, the analyst consensus on Black Diamond Therapeutics is a Moderate Buy with an average price target of $12.00, which is a 160.3% upside from current levels. In a report issued on March 12, TD Cowen also maintained a Buy rating on the stock.

See the top stocks recommended by analysts >>

I-MAB (IMAB)

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on I-MAB, with a price target of $8.00. The company’s shares closed last Friday at $1.86.

According to TipRanks.com, Fein is a 5-star analyst with an average return of 14.6% and a 48.9% success rate. Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Amylyx Pharmaceuticals Inc, and Deciphera Pharmaceuticals.

I-MAB has an analyst consensus of Strong Buy, with a price target consensus of $6.33, representing a 272.4% upside. In a report issued on March 15, Needham also maintained a Buy rating on the stock with a $6.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BDTX: